Found 20 matching trials
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
N/AThis is a noninterventional, observational, long-term follow-up (LTFU) stud...
Location
UC San Diego Moores Cancer Center
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
PHASE1This study will evaluate the safety and efficacy of a recombinant adeno-ass...
Status
Active Not Recruiting
A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa
PHASE3The purpose of the study is to assess the safety and tolerability of bilate...
Status
Active Not Recruiting
Location
National Hospital Organization Tokyo Medical Center
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
PHASE3A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked re...
Status
Active Not Recruiting
Location
Shiley Eye Institute Jacobs Retina Center
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)
PHASE1Phase 1 of the study is a dose escalation of the subretinal administration ...
Location
Massachusetts Eye and Ear Institute
Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN
PHASE2This is a Phase 2, multicenter, open-label, 2-cohort (Locoregionally Advanc...
Location
University of California San Diego, UCSD
Long-term Follow-up Gene Therapy Study for RPGR- XLRP
N/AThis is a long-term follow-up study assessing safety of patients for up to ...
Location
Massachusetts Eye and Ear Infirmary
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
N/AThe purpose of the study is to identify a cohort of Japanese participants w...
Location
National Hospital Organization Tokyo Medical Center
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112
PHASE1The objective of the study is to evaluate the safety, tolerability and effi...
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
PHASE2This study will evaluate and compare the safety, efficacy, and tolerability...
Status
Active Not Recruiting
Location
Retina Macula Institute of Arizona